Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ASIC1 | P78348 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | FNTA | P49354 | 1/20 | 0.31 |
| ▸ | FNTB | P49356 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23577116 | 1.00 | ASIC1 (0.33) | ASIC1KDM4EMEN1ALDH1A1LMNA | |
| SCHEMBL23576883 | 0.91 | ASIC1 (0.33) | ASIC1FNTAFNTBOPRD1 | |
| SCHEMBL29909412 | 0.91 | ASIC1 (0.33) | ASIC1FNTAFNTBOPRD1 | |
| SCHEMBL29909317 | 0.90 | DHODH (0.33) | KDM4EMEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL23576639 | 0.90 | DHODH (0.33) | KDM4EMEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL23576641 | 0.89 | FNTA (0.35) | KDM4EALDH1A1MAPTFNTAFNTB | |
| SCHEMBL29909377 | 0.89 | FNTA (0.35) | KDM4EALDH1A1MAPTFNTAFNTB | |
| SCHEMBL29909055 | 0.88 | ALDH1A1 (0.36) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| SCHEMBL23576801 | 0.88 | ALDH1A1 (0.36) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| SCHEMBL23576713 | 0.86 | OPRD1 (0.34) | MAPTFNTAFNTBOPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4081305-A1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | Carna Biosciences, Inc. (JP) | 2022-11-02 | — | — | EP | disclosed |